Status:
COMPLETED
Role of Dutasteride in Treatment of Chronic Prostatitis
Lead Sponsor:
Ain Shams University
Conditions:
Dutasteride
Category IIIB Chronic Prostatitis
Eligibility:
MALE
40-70 years
Phase:
PHASE2
PHASE3
Brief Summary
this placebo controlled study aims to evaluate the efficacy of Dutasteride in the management of Chronic prostatitis type 3.
Detailed Description
Nonbacterial prostatitis refers to a condition that affects patients who present with symptoms of prostatitis without a positive culture for urine or expressed prostate secretions (EPS). With time our...
Eligibility Criteria
Inclusion
- patients aged between 40 and 70 years old, diagnosed with chronic prostatitis based on the presence of pelvic pain for ≥3 months of the preceding 6 months
Exclusion
- Patients with bacterial prostatitis
- documented site of infection along the urinary tract,
- urinary bladder tumors
- prostate cancer
- previous history of pelvic radiation or chemotherapy were excluded from our study.
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04756206
Start Date
January 1 2019
End Date
September 1 2020
Last Update
February 16 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Urology department - ain shams university
Cairo, Egypt, 11361